pharmaceuticals

pharmaceuticals Articles

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
Although Shire is not seeing much of a bump in its share price, the firm is creating a lot of value with its most recent submission to the FDA.
Teva Pharmaceutical saw its shares make a small gain on Wednesday after the firm announced the exclusive launch of a generic version of Reyataz capsules in the United States.
Mallinckrodt has seen its shares rise on news that it was acquiring Sucampo Pharmaceuticals for roughly $840 million.
Paratek Pharmaceuticals saw its shares make a handy gain on Thursday after the firm announced that the FDA accepted its New Drug Application for the review of Seysara for the treatment of moderate to...
Portola Pharmaceuticals shares saw a handy gain on Tuesday after the company announced that it received a key approval from the FDA.
Valeant Pharmaceuticals shares made a spectacular crash over the course of 2015 to 2017, and it looks like they may now be on the path to recovery.
Teva Pharmaceutical Industries kicked off the week by announced an FDA for its treatment for migraines.
Shares of Pfizer appeared to be headed for a new high after the company announced that the FDA had approved its treatment for adult patients with active psoriatic arthritis.
Another company has decided that the best time to fire a large number of people is just before the holidays.
Teva Pharmaceutical Industries shares turned south on Wednesday after the company said that it would be announcing its restructuring plan on Thursday.
Cellectis saw its shares make a handy gain early on Wednesday after the firm announced preliminary data from its two Phase 1 studies in conjunction with Pfizer.
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
A generic version of Viagra is coming to America, but will existing customers be willing to switch over to a generic version of the pill?
Alexion Pharmaceuticals shares saw a handy gain early on Friday after the New York Times reported that there might be some increasing activist movement in the stock.